CRS Clinical Research Services Wuppertal GmbH
Aprather Weg 18a | Gebäude 429
+49 202 281 52 - 0
CRS Wuppertal – The CPU with a broad range of experience in CVD trials
CRS Wuppertal is located in the heart of Bergisch Triangle Remscheid, Solingen and Wuppertal. In the immediate catchment area are the Ruhr region and the Rhein district. The clinic is located in the Wuppertal research centre of the Bayer site in Wuppertal Elberfeld on Aprather Weg - easily accessible for study participants and customers from Wuppertal and outside.
The main working field of CRS Wuppertal is the performance of phase-I trials related to metabolic & cardiovascular diseases, even if complex bioanalytical sample preparation is required. The clinic is well experienced in the handling of complex ECG trials designs, e.g. PK designs, bioavailability and multiple-dose studies and is familiar with various types of applications (intraveanously, transdermally, orally or subcutaneously).
Computerized ECG devices and an EDC system impedance monitors with SpO2 monitoring, ECG, Triple ECG's, RF measurements for 1 minute, telemetry monitoring, Schellong test, lung function and ophthalmologic measurement methods allow the continuous supervision and evaluation of medical assessments.
- Infrastructure & Location
CRS-Wuppertal is located in the research centre of the Bayer site in Wuppertal Elberfeld. The unit reaches over three floors and allows in-house and outpatient clinical trial activities in parallel without interfering each other. A separate entrance, an automatic access control system and an independent technical infrastructure guarantees for a strict segregation from the circumjacent Bayer facilities.
CRS-Wuppertal gains a total bed capacity of 24 overnight beds equipped with vital sign monitoring systems.
In an intensive care unit 12 beds can be monitored via an ECG, SpO2 and vital signs monitoring system, a computerized ECG device and an EDC system whereas 9 additional beds are available for standard monitoring in an ambulatory setting. Besides, there exists direct access to a study room for pulmonary function tests and for ophthalmologic examinations.
Furthermore, 4 laboratory areas for direct sample preparation of blood and urine samples over an EDC system are available.
The unit was newly built by the Bayer Pharma AG in 1984 and meets the latest technical and logistical standards of clinical research.
As of July 2013 the former Bayer phase-I unit continues its work as the newly established CRS Clinical Research Services Wuppertal GmbH with all its personnel, equipment and experience. Nowadays, Dr. Torben Thomsen is the managing director of CRS-Wuppertal.